Furthermore, soluble recombinant Ig1&2 can act as a decoy receptor to inhibit PTPRS expressed by fibroblasts binding to PG, thereby be used to treat arthritis (Figure 2A). This evidence concerns the gene PTPRS and arthritic joint disease.